Table 1.

Salient clinical features of the three patients with TA-TMA

Pt no	Age (yrs)	Sex	Diagnosis	Transplant	GVHD site and grade	Symptoms	Serum LDH baseline (U/L)	Serum LDH max (U/L)	Serum creatinine baseline (mg/dl)	Serum creatinine Max (mg/dl)	DF dose mg/kg/day	Duration of DF (days)	Outcome	Cause of death
1	24	M	AML-CR2	Haplo	Nil	Altered sensorium	405	2332	0.6	1.18	7.5	7	Alive	NA
						Acute renal failure
2	29	M	CML-AP	MSD	Gut- II	Altered sensorium	143	730	0.81	0.97	4.0	9	Alive	NA
						Seizures
3	49	M	ALL-CR1	MUD	Gut-III	Diarrhea	178	775	0.68	1.7	7.5	19	Dead	Sepsis
						Ascites
						Altered sensorium
						Acute renal failure

MSD matched sibling donor, MUD matched unrelated donor